Cary Goldsman, M.D.
NPI 1851473011 · Specialist · Staten Island, NY
Enrolled with Medicare as Practitioner - Dermatology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Cary Goldsman, M.D. is a Specialist provider in Staten Island, NY (NPI 1851473011).
Provider details
- NPI number
- 1851473011
- Entity type
- Individual
- Primary specialty
- SpecialistOther Service Providers
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 157529 (NY)
Specialties & taxonomies
Other Service Providers
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
19 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
1,795 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Established Patient Office Or Other Outpatient Visit With Low Level OD Decision Making, If Using Time, 20 Minutes Or More99213 | 742 | $104 |
| Destruction of Precancer Skin Growth, 2-14 Growths17003 | 268 | $8 |
| Destruction of Precancer Skin Growth, 15 Or More Growths17004 | 185 | $195 |
| Destruction of Skin Growth, 15 Or More Growths17111 | 181 | $155 |
| Destruction of Skin Growth, 1-14 Growths17110 | 121 | $132 |
| Biopsy of Related Skin Growth, First Growth11102 | 118 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 16 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Ketoconazole | 370 | 156 |
| Clobetasol Propionate | 238 | 127 |
| Clotrimazole | 211 | 98 |
| Betamethasone/Propylene Glycbrand: Betamethasone Diprop Augmented | 145 | 75 |
| Mometasone Furoate | 107 | 61 |
| Mupirocin | 77 | 49 |
| Betamethasone Dipropionate | 73 | 33 |
| Ammonium Lactate |
Practice location
Mailing address
Registry dates
- Enumerated
- 2006-10-19
- Last updated
- 2007-07-30
Frequently asked questions
- What is Cary Goldsman's NPI number?
- Cary Goldsman's National Provider Identifier (NPI) is 1851473011, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What is Cary Goldsman's specialty?
- Cary Goldsman is listed in the NPPES registry with a primary specialty of Specialist (Other Service Providers).
- Where is Cary Goldsman located?
- Cary Goldsman's practice location on file with NPPES is 2344 Victory Blvd, Staten Island, NY 10314-6607.
- What is Cary Goldsman's phone number?
- The practice phone number listed in the NPPES registry for Cary Goldsman is (718) 494-7546.
- Does Cary Goldsman accept Medicare?
- Cary Goldsman is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Is Cary Goldsman's NPI active?
- Yes — Cary Goldsman's NPI (1851473011) is active in the NPPES registry as of the last update on 2007-07-30.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.